Dietary Intake and Nutrient Status of Children With ADHD

This study has been completed.
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by:
University of British Columbia
ClinicalTrials.gov Identifier:
NCT00434928
First received: February 13, 2007
Last updated: NA
Last verified: February 2007
History: No changes posted

February 13, 2007
February 13, 2007
January 2006
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Dietary Intake and Nutrient Status of Children With ADHD
Dietary Intake and Nutrient Status of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Assess the dietary intake of children aged 6-12 years by means of a 24-hour recall and 3-day food record and asses the nutrient status of Vitamin B6, serum ferritin, serum zinc and serum copper of the same children by means of standard laboratory assessments.

  • To document the use of vitamin and vitamin-mineral supplements
  • To determine the percent consumption of low nutrient density (LND) foods
  • To compare the dietary intake of ADHD children with the established standards of the Dietary Reference Intakes (DRIs)
  • To compare the dietary intake of children with ADHD to the dietary recommendations of Canada’s Food Guide for Healthy Eating
  • To determine whether dietary intake is moderated by drug treatment
  • To assess the pyridoxal-5’-phosphate (PLP), serum ferritin, serum zinc, and serum copper status of ADHD by standard laboratory blood test
  • to measure height and weight in ADHD children
Observational
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Not Provided
Not Provided
Not Provided
Not Provided
Attention Deficit Hyperactivity Disorder
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
January 2007
Not Provided

Inclusion Criteria:

  • Primary diagnosis of ADHD
  • Age 6-12 years inclusive

Exclusion Criteria:

  • No use of medication that affects dietary intake (eg. Risperdal)
Both
6 Years to 12 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00434928
H05-70464, W05-0185
Not Provided
Not Provided
University of British Columbia
Eli Lilly and Company
Principal Investigator: Margaret D. Weiss, MD University of British Columbia
University of British Columbia
February 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP